The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The value of TOP2A as a target for anthracycline-based chemotherapy in advanced endometrial carcinoma (EC): NRG Oncology/Gynecology Oncology Group study.
 
Tatyana A. Grushko
No Relationships to Disclose
 
Virginia L. Filiaci
No Relationships to Disclose
 
Anthony G. Montag
No Relationships to Disclose
 
Marsha A. Apushkin
No Relationships to Disclose
 
Brandon Marzullo
No Relationships to Disclose
 
Laura Monovich
No Relationships to Disclose
 
Nilsa C. Ramirez
No Relationships to Disclose
 
Michael J. Birrer
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
 
Olufunmilayo I. Olopade
No Relationships to Disclose
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
Other Relationship - Aeterna Zentaris